These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3612957)

  • 1. Antigenic structure and variation in an influenza virus N9 neuraminidase.
    Webster RG; Air GM; Metzger DW; Colman PM; Varghese JN; Baker AT; Laver WG
    J Virol; 1987 Sep; 61(9):2910-6. PubMed ID: 3612957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase.
    Air GM; Laver WG; Webster RG
    J Virol; 1990 Dec; 64(12):5797-803. PubMed ID: 1700825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase.
    Air GM; Els MC; Brown LE; Laver WG; Webster RG
    Virology; 1985 Sep; 145(2):237-48. PubMed ID: 2411049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).
    Gulati U; Hwang CC; Venkatramani L; Gulati S; Stray SJ; Lee JT; Laver WG; Bochkarev A; Zlotnick A; Air GM
    J Virol; 2002 Dec; 76(23):12274-80. PubMed ID: 12414967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene and protein sequence of an influenza neuraminidase with hemagglutinin activity.
    Air GM; Ritchie LR; Laver WG; Colman PM
    Virology; 1985 Aug; 145(1):117-22. PubMed ID: 4013081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies.
    Webster RG; Brown LE; Laver WG
    Virology; 1984 May; 135(1):30-42. PubMed ID: 6203218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus neuraminidase with hemagglutinin activity.
    Laver WG; Colman PM; Webster RG; Hinshaw VS; Air GM
    Virology; 1984 Sep; 137(2):314-23. PubMed ID: 6485252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10.
    Lee JT; Air GM
    Virology; 2002 Sep; 300(2):255-68. PubMed ID: 12350356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.
    Baker AT; Varghese JN; Laver WG; Air GM; Colman PM
    Proteins; 1987; 2(2):111-7. PubMed ID: 3447170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
    Bossart-Whitaker P; Carson M; Babu YS; Smith CD; Laver WG; Air GM
    J Mol Biol; 1993 Aug; 232(4):1069-83. PubMed ID: 8371267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants.
    Tulip WR; Varghese JN; Baker AT; van Donkelaar A; Laver WG; Webster RG; Colman PM
    J Mol Biol; 1991 Sep; 221(2):487-97. PubMed ID: 1920429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence of the neuraminidase gene of influenza virus A/Tokyo/3/67 and previously uncharacterized monoclonal variants.
    Lentz MR; Air GM; Laver WG; Webster RG
    Virology; 1984 May; 135(1):257-65. PubMed ID: 6203216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
    Nuss JM; Whitaker PB; Air GM
    Proteins; 1993 Feb; 15(2):121-32. PubMed ID: 7680132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
    Pruett PS; Air GM
    Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer of the hemagglutinin activity of influenza virus neuraminidase subtype N9 into an N2 neuraminidase background.
    Nuss JM; Air GM
    Virology; 1991 Aug; 183(2):496-504. PubMed ID: 1853557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.
    Saito T; Taylor G; Laver WG; Kawaoka Y; Webster RG
    J Virol; 1994 Mar; 68(3):1790-6. PubMed ID: 7509002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of amino acid residues important to the neuraminidase activity of the HN glycoprotein of Newcastle disease virus.
    Iorio RM; Syddall RJ; Glickman RL; Riel AM; Sheehan JP; Bratt MA
    Virology; 1989 Nov; 173(1):196-204. PubMed ID: 2479168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An 18-amino acid deletion in an influenza neuraminidase.
    Els MC; Air GM; Murti KG; Webster RG; Laver WG
    Virology; 1985 Apr; 142(2):241-7. PubMed ID: 4060573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the requirements for an antibody epitope on influenza virus neuraminidase: how tolerant are protein epitopes?
    Nuss JM; Air GM
    J Mol Biol; 1994 Jan; 235(2):747-59. PubMed ID: 7507170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
    Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.